Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
Edesa Biotech, Inc.
EDSA
Core
Secondary Endpoint Mentioned
Clinical Trial Result
Clinical Hold
Patient Enrollment Velocity
Lead Asset Progress
Indication Expansion
Other
Interim Data Positive
Publication Positive
Patient Retention High
Enrollment Ahead Of Schedule
Biotech Risk
Clinical Hold Active
Other
Ipo Net Proceeds Disclosure
Amendment Modification Waiver Clause
Transfer And Demand Rights Limitations
Market Price Definition
Fcpa Compliance Representation
Form S3 Shelf Registration Disclosure
New York Jurisdiction Clause
Use Of Proceeds Disclosure
Hazardous Materials Definition
Corporate Authority Representation
Corporate Organization And Standing Representation
Legal Opinion Methodology Disclosure
Indemnification Consent Requirement
Nyse Listing Disclosure
No Regulatory Approval Required
Other
Rsu Psu Vesting Schedule Disclosed
Warrant Valued Black Scholes
Net Loss Reported
Financing Activities Cash Flow Disclosure
Equity Plan Share Reserve Disclosure
Liquidity Position Snapshot Disclosed
Cash Flow Statement Investing Activities
Stock Option Grant Disclosed
Form S3 Shelf Registration Disclosure
Interim Data Positive
Insider Buying
Institutional Investment
Protocol Amended
Core
Clinical Trial Result
Combination Therapy Mentioned
Other
Corporate Organization And Standing Representation
Indemnification Consent Requirement
Corporate Authority Representation
Fcpa Compliance Representation
Sanctions Compliance Representation
Conflicted Defense Counsel Provision
Form 8K Filing Disclosure
Registration Rights Piggyback Provision
Amendment Modification Waiver Clause
Survival Of Representations Warranties Clause
Market Price Definition
Tax Advisor Consultation Urged
Nyse Listing Disclosure
Core
Indication Expansion
Lead Asset Progress
Core
Clinical Trial Result
Combination Therapy Mentioned
Secondary Endpoint Mentioned
Other
Patient Retention High
Interim Data Positive
Expanded Access Program Active
Fda Aligned
Publication Positive
Enrollment Ahead Of Schedule
Mineral Exploration Delineation
Fast Track Designation Received
Healthcare
Mlr Stable
Other
Auditor Appointment Ratification
Quorum Presence Disclosed
Equity Plan Share Reserve Disclosure
Classified Board Director Election
Equity Award Plan Types Enumerated
Other
Rsu Psu Vesting Schedule Disclosed
Warrant Valued Black Scholes
Net Loss Reported
Financing Activities Cash Flow Disclosure
Equity Plan Share Reserve Disclosure
Cash Flow Statement Investing Activities
Liquidity Position Snapshot Disclosed
Operating Lease Rent Expense Disclosed
Stock Option Grant Disclosed
Interim Data Positive
Core
Indication Expansion
Clinical Trial Result